nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.31	0.391	CbGbCtD
Indacaterol—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0439	0.0552	CbGbCtD
Indacaterol—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0397	0.0499	CbGbCtD
Indacaterol—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0342	0.0431	CbGbCtD
Indacaterol—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0332	0.0418	CbGbCtD
Indacaterol—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0301	0.0378	CbGbCtD
Indacaterol—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0301	0.0378	CbGbCtD
Indacaterol—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0288	0.0363	CbGbCtD
Indacaterol—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0279	0.0352	CbGbCtD
Indacaterol—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0263	0.0331	CbGbCtD
Indacaterol—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0263	0.0331	CbGbCtD
Indacaterol—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0238	0.0299	CbGbCtD
Indacaterol—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0238	0.0299	CbGbCtD
Indacaterol—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0223	0.0281	CbGbCtD
Indacaterol—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0205	0.0258	CbGbCtD
Indacaterol—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0199	0.0251	CbGbCtD
Indacaterol—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.018	0.0227	CbGbCtD
Indacaterol—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.018	0.0227	CbGbCtD
Indacaterol—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0173	0.0217	CbGbCtD
Indacaterol—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.00307	CcSEcCtD
Indacaterol—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00063	0.00307	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000628	0.00306	CcSEcCtD
Indacaterol—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.000627	0.00306	CcSEcCtD
Indacaterol—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000627	0.00306	CcSEcCtD
Indacaterol—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000627	0.00306	CcSEcCtD
Indacaterol—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000625	0.00304	CcSEcCtD
Indacaterol—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000623	0.00304	CcSEcCtD
Indacaterol—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000619	0.00302	CcSEcCtD
Indacaterol—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.000614	0.00299	CcSEcCtD
Indacaterol—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000614	0.00299	CcSEcCtD
Indacaterol—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.000611	0.00298	CcSEcCtD
Indacaterol—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000609	0.00297	CcSEcCtD
Indacaterol—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000605	0.00295	CcSEcCtD
Indacaterol—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000605	0.00295	CcSEcCtD
Indacaterol—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000603	0.00294	CcSEcCtD
Indacaterol—Infection—Abacavir—acquired immunodeficiency syndrome	0.000602	0.00293	CcSEcCtD
Indacaterol—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000599	0.00292	CcSEcCtD
Indacaterol—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000597	0.00291	CcSEcCtD
Indacaterol—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00291	CcSEcCtD
Indacaterol—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000596	0.0029	CcSEcCtD
Indacaterol—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000594	0.0029	CcSEcCtD
Indacaterol—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000589	0.00287	CcSEcCtD
Indacaterol—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000588	0.00287	CcSEcCtD
Indacaterol—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.000588	0.00287	CcSEcCtD
Indacaterol—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000586	0.00285	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00058	0.00283	CcSEcCtD
Indacaterol—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000576	0.00281	CcSEcCtD
Indacaterol—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000576	0.0028	CcSEcCtD
Indacaterol—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.0028	CcSEcCtD
Indacaterol—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000572	0.00279	CcSEcCtD
Indacaterol—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000572	0.00279	CcSEcCtD
Indacaterol—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000571	0.00278	CcSEcCtD
Indacaterol—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000563	0.00274	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000562	0.00274	CcSEcCtD
Indacaterol—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.000561	0.00274	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00056	0.00273	CcSEcCtD
Indacaterol—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.00272	CcSEcCtD
Indacaterol—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.00272	CcSEcCtD
Indacaterol—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000554	0.0027	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000554	0.0027	CcSEcCtD
Indacaterol—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000553	0.0027	CcSEcCtD
Indacaterol—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000552	0.00269	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000552	0.00269	CcSEcCtD
Indacaterol—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000551	0.00268	CcSEcCtD
Indacaterol—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00055	0.00268	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00055	0.00268	CcSEcCtD
Indacaterol—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00055	0.00268	CcSEcCtD
Indacaterol—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000547	0.00267	CcSEcCtD
Indacaterol—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000544	0.00265	CcSEcCtD
Indacaterol—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000543	0.00265	CcSEcCtD
Indacaterol—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00054	0.00263	CcSEcCtD
Indacaterol—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000539	0.00263	CcSEcCtD
Indacaterol—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000538	0.00262	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000533	0.0026	CcSEcCtD
Indacaterol—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000532	0.00259	CcSEcCtD
Indacaterol—Cough—Indinavir—acquired immunodeficiency syndrome	0.000532	0.00259	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000531	0.00259	CcSEcCtD
Indacaterol—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000529	0.00258	CcSEcCtD
Indacaterol—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00257	CcSEcCtD
Indacaterol—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000528	0.00257	CcSEcCtD
Indacaterol—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000527	0.00257	CcSEcCtD
Indacaterol—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000524	0.00255	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000523	0.00255	CcSEcCtD
Indacaterol—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.00255	CcSEcCtD
Indacaterol—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000522	0.00254	CcSEcCtD
Indacaterol—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000519	0.00253	CcSEcCtD
Indacaterol—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000519	0.00253	CcSEcCtD
Indacaterol—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000519	0.00253	CcSEcCtD
Indacaterol—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000517	0.00252	CcSEcCtD
Indacaterol—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000516	0.00251	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00251	CcSEcCtD
Indacaterol—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000509	0.00248	CcSEcCtD
Indacaterol—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000509	0.00248	CcSEcCtD
Indacaterol—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00248	CcSEcCtD
Indacaterol—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000509	0.00248	CcSEcCtD
Indacaterol—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000507	0.00247	CcSEcCtD
Indacaterol—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000507	0.00247	CcSEcCtD
Indacaterol—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000502	0.00245	CcSEcCtD
Indacaterol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000501	0.00244	CcSEcCtD
Indacaterol—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000495	0.00241	CcSEcCtD
Indacaterol—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00049	0.00239	CcSEcCtD
Indacaterol—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000488	0.00238	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000487	0.00237	CcSEcCtD
Indacaterol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000487	0.00237	CcSEcCtD
Indacaterol—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000487	0.00237	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.00237	CcSEcCtD
Indacaterol—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00236	CcSEcCtD
Indacaterol—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000484	0.00236	CcSEcCtD
Indacaterol—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000483	0.00235	CcSEcCtD
Indacaterol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000481	0.00234	CcSEcCtD
Indacaterol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00048	0.00234	CcSEcCtD
Indacaterol—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000479	0.00234	CcSEcCtD
Indacaterol—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000477	0.00232	CcSEcCtD
Indacaterol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000477	0.00232	CcSEcCtD
Indacaterol—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000471	0.0023	CcSEcCtD
Indacaterol—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000471	0.00229	CcSEcCtD
Indacaterol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000469	0.00229	CcSEcCtD
Indacaterol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00228	CcSEcCtD
Indacaterol—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00228	CcSEcCtD
Indacaterol—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000468	0.00228	CcSEcCtD
Indacaterol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000462	0.00225	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.00225	CcSEcCtD
Indacaterol—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000461	0.00224	CcSEcCtD
Indacaterol—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000459	0.00224	CcSEcCtD
Indacaterol—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000458	0.00223	CcSEcCtD
Indacaterol—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000458	0.00223	CcSEcCtD
Indacaterol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00223	CcSEcCtD
Indacaterol—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000456	0.00222	CcSEcCtD
Indacaterol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000455	0.00221	CcSEcCtD
Indacaterol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000453	0.00221	CcSEcCtD
Indacaterol—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000453	0.00221	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000453	0.00221	CcSEcCtD
Indacaterol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000451	0.0022	CcSEcCtD
Indacaterol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00045	0.00219	CcSEcCtD
Indacaterol—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.00219	CcSEcCtD
Indacaterol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000447	0.00218	CcSEcCtD
Indacaterol—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000446	0.00218	CcSEcCtD
Indacaterol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000446	0.00218	CcSEcCtD
Indacaterol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000446	0.00218	CcSEcCtD
Indacaterol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000446	0.00217	CcSEcCtD
Indacaterol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.00217	CcSEcCtD
Indacaterol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000444	0.00216	CcSEcCtD
Indacaterol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000443	0.00216	CcSEcCtD
Indacaterol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00044	0.00215	CcSEcCtD
Indacaterol—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000439	0.00214	CcSEcCtD
Indacaterol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000438	0.00213	CcSEcCtD
Indacaterol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000437	0.00213	CcSEcCtD
Indacaterol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000436	0.00213	CcSEcCtD
Indacaterol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000435	0.00212	CcSEcCtD
Indacaterol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.00211	CcSEcCtD
Indacaterol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.00211	CcSEcCtD
Indacaterol—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000432	0.00211	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.0021	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000429	0.00209	CcSEcCtD
Indacaterol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000429	0.00209	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000428	0.00209	CcSEcCtD
Indacaterol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000428	0.00208	CcSEcCtD
Indacaterol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000424	0.00207	CcSEcCtD
Indacaterol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000422	0.00206	CcSEcCtD
Indacaterol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000421	0.00205	CcSEcCtD
Indacaterol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00042	0.00205	CcSEcCtD
Indacaterol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000419	0.00204	CcSEcCtD
Indacaterol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00203	CcSEcCtD
Indacaterol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00203	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00202	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000409	0.002	CcSEcCtD
Indacaterol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000408	0.00199	CcSEcCtD
Indacaterol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000408	0.00199	CcSEcCtD
Indacaterol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000408	0.00199	CcSEcCtD
Indacaterol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.00199	CcSEcCtD
Indacaterol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000407	0.00198	CcSEcCtD
Indacaterol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000406	0.00198	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.00198	CcSEcCtD
Indacaterol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000404	0.00197	CcSEcCtD
Indacaterol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000404	0.00197	CcSEcCtD
Indacaterol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000402	0.00196	CcSEcCtD
Indacaterol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000401	0.00196	CcSEcCtD
Indacaterol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00195	CcSEcCtD
Indacaterol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000401	0.00195	CcSEcCtD
Indacaterol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000399	0.00194	CcSEcCtD
Indacaterol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.00194	CcSEcCtD
Indacaterol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.00194	CcSEcCtD
Indacaterol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000397	0.00194	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00193	CcSEcCtD
Indacaterol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000392	0.00191	CcSEcCtD
Indacaterol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.0019	CcSEcCtD
Indacaterol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000389	0.0019	CcSEcCtD
Indacaterol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000389	0.00189	CcSEcCtD
Indacaterol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000389	0.00189	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000388	0.00189	CcSEcCtD
Indacaterol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000388	0.00189	CcSEcCtD
Indacaterol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000387	0.00189	CcSEcCtD
Indacaterol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000386	0.00188	CcSEcCtD
Indacaterol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000385	0.00188	CcSEcCtD
Indacaterol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00186	CcSEcCtD
Indacaterol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00186	CcSEcCtD
Indacaterol—Headache—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00185	CcSEcCtD
Indacaterol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000379	0.00185	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.00185	CcSEcCtD
Indacaterol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000378	0.00184	CcSEcCtD
Indacaterol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000378	0.00184	CcSEcCtD
Indacaterol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000374	0.00182	CcSEcCtD
Indacaterol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000373	0.00182	CcSEcCtD
Indacaterol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000371	0.00181	CcSEcCtD
Indacaterol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00181	CcSEcCtD
Indacaterol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000366	0.00179	CcSEcCtD
Indacaterol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000366	0.00178	CcSEcCtD
Indacaterol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000365	0.00178	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.00178	CcSEcCtD
Indacaterol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00036	0.00175	CcSEcCtD
Indacaterol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000359	0.00175	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.00175	CcSEcCtD
Indacaterol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00174	CcSEcCtD
Indacaterol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000353	0.00172	CcSEcCtD
Indacaterol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00171	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.00169	CcSEcCtD
Indacaterol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00169	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00168	CcSEcCtD
Indacaterol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00167	CcSEcCtD
Indacaterol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00166	CcSEcCtD
Indacaterol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00164	CcSEcCtD
Indacaterol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00164	CcSEcCtD
Indacaterol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00163	CcSEcCtD
Indacaterol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00162	CcSEcCtD
Indacaterol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00161	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00161	CcSEcCtD
Indacaterol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000329	0.0016	CcSEcCtD
Indacaterol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.00155	CcSEcCtD
Indacaterol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000318	0.00155	CcSEcCtD
Indacaterol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00153	CcSEcCtD
Indacaterol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00153	CcSEcCtD
Indacaterol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00152	CcSEcCtD
Indacaterol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00151	CcSEcCtD
Indacaterol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.00149	CcSEcCtD
Indacaterol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.00145	CcSEcCtD
Indacaterol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00144	CcSEcCtD
Indacaterol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00144	CcSEcCtD
Indacaterol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00144	CcSEcCtD
Indacaterol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00144	CcSEcCtD
Indacaterol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.00143	CcSEcCtD
Indacaterol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00143	CcSEcCtD
Indacaterol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.00138	CcSEcCtD
Indacaterol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.00138	CcSEcCtD
Indacaterol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00138	CcSEcCtD
Indacaterol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00137	CcSEcCtD
Indacaterol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00137	CcSEcCtD
Indacaterol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00136	CcSEcCtD
Indacaterol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00134	CcSEcCtD
Indacaterol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00132	CcSEcCtD
Indacaterol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.0013	CcSEcCtD
Indacaterol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00129	CcSEcCtD
Indacaterol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00128	CcSEcCtD
Indacaterol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00128	CcSEcCtD
Indacaterol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00127	CcSEcCtD
Indacaterol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00123	CcSEcCtD
Indacaterol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00123	CcSEcCtD
Indacaterol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00123	CcSEcCtD
Indacaterol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00122	CcSEcCtD
Indacaterol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.0012	CcSEcCtD
Indacaterol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00117	CcSEcCtD
Indacaterol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00117	CcSEcCtD
Indacaterol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00116	CcSEcCtD
Indacaterol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00116	CcSEcCtD
Indacaterol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.0011	CcSEcCtD
Indacaterol—UGT1A1—blood plasma—acquired immunodeficiency syndrome	8.41e-05	0.226	CbGeAlD
Indacaterol—UGT1A1—digestive system—acquired immunodeficiency syndrome	3.23e-05	0.087	CbGeAlD
Indacaterol—UGT1A1—blood—acquired immunodeficiency syndrome	3.08e-05	0.0829	CbGeAlD
Indacaterol—CYP3A4—blood plasma—acquired immunodeficiency syndrome	2.69e-05	0.0725	CbGeAlD
Indacaterol—ABCB1—blood plasma—acquired immunodeficiency syndrome	1.91e-05	0.0513	CbGeAlD
Indacaterol—ADRB1—lung—acquired immunodeficiency syndrome	1.83e-05	0.0492	CbGeAlD
Indacaterol—ADRB1—nervous system—acquired immunodeficiency syndrome	1.69e-05	0.0456	CbGeAlD
Indacaterol—ADRB1—central nervous system—acquired immunodeficiency syndrome	1.63e-05	0.0439	CbGeAlD
Indacaterol—ADRB1—brain—acquired immunodeficiency syndrome	1.29e-05	0.0348	CbGeAlD
Indacaterol—ABCB1—retina—acquired immunodeficiency syndrome	1.04e-05	0.0281	CbGeAlD
Indacaterol—CYP3A4—digestive system—acquired immunodeficiency syndrome	1.04e-05	0.0279	CbGeAlD
Indacaterol—CYP3A4—blood—acquired immunodeficiency syndrome	9.87e-06	0.0266	CbGeAlD
Indacaterol—CYP3A4—nervous system—acquired immunodeficiency syndrome	8.01e-06	0.0216	CbGeAlD
Indacaterol—CYP3A4—central nervous system—acquired immunodeficiency syndrome	7.72e-06	0.0208	CbGeAlD
Indacaterol—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	7.43e-06	0.02	CbGeAlD
Indacaterol—ABCB1—digestive system—acquired immunodeficiency syndrome	7.33e-06	0.0197	CbGeAlD
Indacaterol—ABCB1—blood—acquired immunodeficiency syndrome	6.99e-06	0.0188	CbGeAlD
Indacaterol—ABCB1—bone marrow—acquired immunodeficiency syndrome	6.76e-06	0.0182	CbGeAlD
Indacaterol—ABCB1—spinal cord—acquired immunodeficiency syndrome	6.73e-06	0.0181	CbGeAlD
Indacaterol—ABCB1—vagina—acquired immunodeficiency syndrome	6.48e-06	0.0174	CbGeAlD
Indacaterol—ABCB1—lung—acquired immunodeficiency syndrome	6.13e-06	0.0165	CbGeAlD
Indacaterol—ABCB1—nervous system—acquired immunodeficiency syndrome	5.67e-06	0.0153	CbGeAlD
Indacaterol—ABCB1—central nervous system—acquired immunodeficiency syndrome	5.46e-06	0.0147	CbGeAlD
Indacaterol—ABCB1—brain—acquired immunodeficiency syndrome	4.34e-06	0.0117	CbGeAlD
Indacaterol—ABCB1—lymph node—acquired immunodeficiency syndrome	4.19e-06	0.0113	CbGeAlD
